Complications after BCG immunotherapy – neither a mountain nor a molehill

Re: Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer – a follow-up five years after the start of treatment

Wojciech KrajewskiDepartment of Urology and Oncological Urology, Wrocław Medical University, Wrocław, PolandCorrespondence[email protected]

Sławomir PoletajewDepartment of General, Oncological and Functional Urology, Medical University of Warsaw, Warsaw, Poland

Romuald ZdrojowyDepartment of Urology and Oncological Urology, Wrocław Medical University, Wrocław, Poland

Anna KołodziejDepartment of Urology and Oncological Urology, Wrocław Medical University, Wrocław, Poland

"Complications after BCG immunotherapy – neither a mountain nor a molehill." Scandinavian Journal of Urology, 53(4), pp. 265–266

Disclosure statement

No potential conflict of interest was reported by the authors.

Study data availability

The data used to support the findings of this study are available from the corresponding author upon request.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Complications after BCG immunotherapy – neither a mountain nor a molehill

Re: Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer – a follow-up five years after the start of treatment

Information for

Open access

Opportunities

Help and information

Complications after BCG immunotherapy – neither a mountain nor a molehill

Re: Bladder health in patients treated with BCG instillations for T1G2-G3 bladder cancer – a follow-up five years after the start of treatment

Disclosure statement

Study data availability

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature